EP3253797A4 - Polypeptides de fusion chimiokine-immunoglobuline, compositions, procédé de fabrication et utilisation associés - Google Patents

Polypeptides de fusion chimiokine-immunoglobuline, compositions, procédé de fabrication et utilisation associés Download PDF

Info

Publication number
EP3253797A4
EP3253797A4 EP16747125.9A EP16747125A EP3253797A4 EP 3253797 A4 EP3253797 A4 EP 3253797A4 EP 16747125 A EP16747125 A EP 16747125A EP 3253797 A4 EP3253797 A4 EP 3253797A4
Authority
EP
European Patent Office
Prior art keywords
chemokine
compositions
making
fusion polypeptides
immunoglobulin fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16747125.9A
Other languages
German (de)
English (en)
Other versions
EP3253797A1 (fr
Inventor
James W. Lillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jyant Technologies Inc
Original Assignee
Jyant Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/612,884 external-priority patent/US9249204B2/en
Application filed by Jyant Technologies Inc filed Critical Jyant Technologies Inc
Publication of EP3253797A1 publication Critical patent/EP3253797A1/fr
Publication of EP3253797A4 publication Critical patent/EP3253797A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16747125.9A 2015-02-03 2016-02-02 Polypeptides de fusion chimiokine-immunoglobuline, compositions, procédé de fabrication et utilisation associés Withdrawn EP3253797A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/612,884 US9249204B2 (en) 2011-06-01 2015-02-03 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
PCT/US2016/016191 WO2016126719A1 (fr) 2015-02-03 2016-02-02 Polypeptides de fusion chimiokine-immunoglobuline, compositions, procédé de fabrication et utilisation associés

Publications (2)

Publication Number Publication Date
EP3253797A1 EP3253797A1 (fr) 2017-12-13
EP3253797A4 true EP3253797A4 (fr) 2018-10-03

Family

ID=56564605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16747125.9A Withdrawn EP3253797A4 (fr) 2015-02-03 2016-02-02 Polypeptides de fusion chimiokine-immunoglobuline, compositions, procédé de fabrication et utilisation associés

Country Status (3)

Country Link
EP (1) EP3253797A4 (fr)
CN (1) CN107207603A (fr)
WO (1) WO2016126719A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886241A (zh) * 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
CN113840832A (zh) * 2018-05-14 2021-12-24 狼人治疗公司 可活化白介素-2多肽及其使用方法
JP2021523743A (ja) * 2018-05-15 2021-09-09 カースゲン セラピューティクス カンパニー リミテッドＣａｒｓｇｅｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏ．， Ｌｔｄ． 遺伝子操作された細胞及びその応用
CA3147677A1 (fr) * 2019-08-13 2021-02-18 Elpis Biopharmaceuticals Agonistes beta du recepteur de l'interleukine-2 modifies
CN111440244B (zh) * 2020-04-09 2021-03-16 诺未科技（北京）有限公司 靶向vegfr2的转移性癌疫苗
EP4168431A4 (fr) * 2020-06-21 2024-04-10 Technion Research & Development Foundation Limited Cxcl10 modifié pour l'immunothérapie de maladies cancéreuses
EP4168432A4 (fr) * 2020-06-21 2024-04-17 Technion Research & Development Foundation Limited Cxcl9 et variants de celui-ci pour l'immunothérapie de maladies cancéreuses
CN116322740A (zh) * 2020-07-13 2023-06-23 特兰斯吉恩股份有限公司 免疫抑制的治疗
CN113318120A (zh) * 2021-06-07 2021-08-31 昆明医科大学第二附属医院 一种miR4512及CXCL2在自身免疫性疾病中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (fr) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Usages therapeutiques de variants de chemokine
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
CN101094688B (zh) * 2004-09-13 2013-05-01 建新公司 多聚构建体
GB0605735D0 (en) * 2006-03-22 2006-05-03 Immunobiology Ltd Composition and method for mediating an immune response

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037305A1 (fr) * 2003-10-16 2005-04-28 Applied Research Systems Ars Holding N.V. Usages therapeutiques de variants de chemokine
US20070036750A1 (en) * 2005-08-12 2007-02-15 Schering Corporation MCP1 fusions
US20100196406A1 (en) * 2007-06-04 2010-08-05 Rappaport Family Institute For Research In The Medical Sciences Agents for the treatment of inflammatory diseases and methods of using same
US20120308565A1 (en) * 2011-06-01 2012-12-06 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130323245A1 (en) * 2011-06-01 2013-12-05 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
US20130330337A1 (en) * 2011-06-01 2013-12-12 Morehouse School Of Medicine Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016126719A1 *

Also Published As

Publication number Publication date
CN107207603A (zh) 2017-09-26
WO2016126719A1 (fr) 2016-08-11
EP3253797A1 (fr) 2017-12-13

Similar Documents

Publication Publication Date Title
IL257030A (en) Multivalent and multispecific cleavage proteins that bind to gitr Preparations containing them and uses thereof
EP3347472A4 (fr) Compositions comprenant des polypeptides de variante cyp76ad1-bêta et utilisations de ces compositions
EP3298033A4 (fr) Compositions et méthodes de reprogrammation de tcr au moyen de protéines de fusion
EP3104865A4 (fr) Des procédés pour préparer et utiliser ledit additif sont en outre décrits.
EP3166892A4 (fr) Compositions anti-calcaire et procédés de fabrication et d'utilisation associés
IL275435A (en) TATK – CDKL5 fusion proteins, preparations, formulations, and their uses
EP3354653A4 (fr) Composé pyrimidine à cycles condensés, intermédiaire, et procédé de préparation, composition et utilisation associée
EP3703676A4 (fr) Composition et procédé pour modifier des polypeptides
EP3136879A4 (fr) Compositions de protéines concentrées et procédés pour les préparer et les utiliser
EP3092248A4 (fr) Polypeptides de fusion et leurs méthodes d'utilisation
EP3170808A4 (fr) Composition de polythiol et procédé de production correspondant
EP3270985A4 (fr) Compositions de polypeptide et leurs procédés d'utilisation
EP3237452A4 (fr) Protéines de fusion et procédés associés
EP3202775A4 (fr) Polypeptide de conotoxine kappa-cptx-bt104, procédé de préparation de celui-ci et application de celui-ci
EP3323825A4 (fr) Composé polypeptidique, son procédé de préparation et son utilisation
EP3315508A4 (fr) Composé polypeptidique, procédé de préparation et leur utilisation
EP3269725A4 (fr) Procédé de production d'une composition protéinique et composition protéinique
EP3146968A4 (fr) Composition k2, procédé pour la préparer et application de celle-ci
EP3202778A4 (fr) Polypeptide de conotoxine kappa-cptx-bt105, et son procédé de préparation et d'application
EP3081581A4 (fr) Diazorésine, composition de résine photosensible et procédé de préparation de la composition de résine photosensible
EP3392263A4 (fr) Composé polypeptidique, son procédé de préparation et son utilisation
EP3394174A4 (fr) Composition, procédé de préparation d'une composition et objet
EP3132790A4 (fr) Composition contenant de l'exénatide et son procédé de préparation
EP3136864A4 (fr) Compositions, procédés de création d'une composition, et méthodes d'utilisation
GB201715817D0 (en) Methods, compositions and uses relating thereto

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170629

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180524BHEP

Ipc: A61K 39/395 20060101ALI20180524BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180904

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20180829BHEP

Ipc: A61K 39/395 20060101ALI20180829BHEP

17Q First examination report despatched

Effective date: 20200203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200616